Literature DB >> 19287561

Aripiprazole in schizotypal personality disorder: a case report.

Ajay Kumar, Ravikant Pinjarkar, Nitin Anand, M Manjula, Suresh Bada Math.   

Abstract

Entities:  

Year:  2008        PMID： 19287561      PMCID： PMC2644468          DOI： 10.4088/pcc.v10n0612a

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  10 in total

1.  The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor.

Authors:  Shaun Jordan; Vuk Koprivica; Ruoyan Chen; Katsura Tottori; Tetsuro Kikuchi; C Anthony Altar
Journal:  Eur J Pharmacol       Date:  2002-04-26       Impact factor: 4.432

2.  The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria.

Authors:  A Raine
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

3.  Amitriptyline and haloperidol in unstable and schizotypal borderline disorders.

Authors:  P H Soloff; A George; S Nathan; P M Schulz; R F Ulrich; J M Perel
Journal:  Psychopharmacol Bull       Date:  1986

Review 4.  Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.

Authors:  Tracy Swainston Harrison; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.

Authors:  S C Goldberg; S C Schulz; P M Schulz; R J Resnick; R M Hamer; R O Friedel
Journal:  Arch Gen Psychiatry       Date:  1986-07

6.  Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder.

Authors:  Matcheri Keshavan; Mujeeb Shad; Paul Soloff; Nina Schooler
Journal:  Schizophr Res       Date:  2004-11-01       Impact factor: 4.939

Review 7.  Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability.

Authors:  Anthony DeLeon; Nick C Patel; M Lynn Crismon
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393

Review 8.  Dopamine partial agonists: a new class of antipsychotic.

Authors:  Jeffrey A Lieberman
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

9.  Risperidone in the treatment of schizotypal personality disorder.

Authors:  Harold W Koenigsberg; Diedre Reynolds; Marianne Goodman; Antonia S New; Vivian Mitropoulou; Robert L Trestman; Jeremy Silverman; Larry J Siever
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

10.  Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.

Authors:  Kevin D Burris; Thaddeus F Molski; Cen Xu; Elaine Ryan; Katsura Tottori; Tetsuro Kikuchi; Frank D Yocca; Perry B Molinoff
Journal:  J Pharmacol Exp Ther       Date:  2002-07       Impact factor: 4.030
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.